Edesa Biotech, Inc.【EDSA】
Market cap
$35.96M
P/E ratio
| Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | Sep 30, 2024 | |
| Research and development | 1 | 2 | 2 | 2 | 3 | 18 | 13 | 5 | 3 |
| General and administrative | 3 | 3 | 3 | 3 | 3 | 6 | 5 | 4 | 4 |
| Loss from operations | - | -4,908,356 | -5,224,546 | -5,078,250 | -6,400,842 | -23,681,332 | -18,370,790 | -9,222,758 | -7,014,744 |
| Reimbursement grant income | - | - | - | - | - | - | - | - | 698,277 |
| Interest income | - | - | - | - | - | 11,165 | 63,523 | 289,846 | 153,498 |
| Misc other income | - | - | - | - | - | - | - | - | 14,766 |
| Foreign exchange loss | -653,333 | 76,800 | 162,028 | -35,059 | -366 | - | -21,114 | -21,742 | -21,042 |
| Nonoperating Income (Expense) | 2 | -110,524 | 194,698 | 40,101 | 37,412 | 10 | - | 849,143 | 845,499 |
| Loss before income taxes | - | - | - | - | - | - | -17,548,124 | -8,373,615 | -6,169,245 |
| Income tax expense | 36,800 | 7,200 | 800 | 800 | 800 | 800 | 800 | 800 | 800 |
| Net loss | -2,843,029 | -5,026,080 | -5,030,648 | -5,038,949 | -6,364,230 | -13,342,350 | 18 | 8 | -6 |
| Exchange differences on translation | - | - | - | - | 54,870 | 81,942 | - | -1,046 | -27,965 |
| Net comprehensive loss | - | - | - | - | -6,309,360 | -13,261,208 | -17,557,264 | -8,375,461 | -6 |
| Loss per common share - basic and diluted (in dollars per share) | -0.36 | -0.57 | - | - | - | - | - | - | -1.93 |